Executive summaries

StHealth Clinical Commissioning Consortium (GPCC), St Helens & Knowsley NHS Trust and GlaxoSmithKline (GSK) UK working in partnership to understand the current management of patients with osteoporosis within this locality.

Both parties have committed resources to support this project, which will run from October 2011 to September 2012.

The objective of this Joint Working project is to understand the current management of osteoporosis within StHealth Clinical Commissioning Consortium and if necessary develop plans for ensuring it conforms to NICE guidelines and standards of care.

Phase 1

To gain insight into the following areas in pilot practices within StHealth GPCC equalling list size of 73,550:

• How patients diagnosed with osteoporosis are currently managed
• Patient Compliance to current treatment regimes including both prescription count and patient experience
• The management of patients who have had a low trauma fracture who may or may not have been diagnosed with osteoporosis
• The management of patients on long term oral corticosteroid treatment regimes with regard to bone health
• Understand adherence to current guidance.
• Evaluate current patient experience and satisfaction with current pathway

Phase 2

• Patients identified as being sub-optimally managed in phase 1 will be recalled and reviewed as per existing guidance by an appropriately qualified healthcare professional
• Depending on the outcomes from phase 1 then there is an opportunity to improve the identification and management of patients diagnosed with osteoporosis or at risk of a fracture across the GPCC.

For further information please contact:

Helen Philpot, Area Business Manager, GSK.
Email: helen.k.philpot@gsk.com

Karen Fox, Integrated Healthcare Manager, GSK.
Email: karen.x.fox@gsk.com

UK/PPM/0065/10 - June 2011

Liverpool Community Health Medicine Management COPD Project Team and GlaxoSmithKline UK Ltd are engaged in joint working to enhance the management of Chronic Obstructive Pulmonary Disease (COPD) to a standard of care defined by NICE (National Institute for Health and Clinical Excellence).

Both parties have committed resources to support this project, which will run from September 2011 – February 2012

The objective of this Joint Working project is to improve quality and productivity in the management of patients with COPD within Liverpool Matchworks and South Central PBC groups.

It is designed to support:

• Improved quality and productivity in the management of patients with COPD within Liverpool.
• Correct diagnosis of COPD
• Prevention of COPD exacerbations through increased patient review and optimisation of medications in line with the NICE COPD guideline 2010 and North Mersey COPD QIPP Guidelines.
• Improved prescribing of licensed medications in COPD in line with NICE COPD guideline 2010 and North Mersey COPD QIPP Guidelines.
• Improved the appropriateness of COPD referrals to secondary care.
• Improvement of COPD care in high secondary care admission practices.
• Improvement in referrals to Pulmonary Rehabilitation Services.
• Improved data quality and capture within the member practices.
• A legacy has been left for continued COPD management by practices.

For further information please contact Helen Philpot, Area Business Manager GSK.
Email: helen.k.philpot@gsk.com
Julie Monaghan Integrated Healthcare Manager GSK.
Email: julie.k.monaghan@gsk.com or
Alison McMinn Pharmaceutical Advisor.
Email: Alison.mcminn@liverpoolch.nhs.uk

UK/PPM/0069/10 August 2011

Lloydspharmacy, Hull PCT and GSK are working together to improve the quality of life of patients who suffer from Chronic Obstructive Pulmonary Disease (COPD).

Lloydspharmacy, GSK and Hull PCT have committed resources to support this project, which will run from September 2011 to April 2012.

Lloydspharmacy, in collaboration with GlaxoSmithKline and Hull PCT will deliver a pharmacy-based patient review service with the aim of improving outcomes for patients with COPD.

This project is designed to:

• Empower patients with COPD to improve their health through education and medicines information
• Improve patient outcomes by enabling COPD patients to have greater control over their condition, potentially improving their quality of life
• Carry out patient assessment and make appropriate interventions and referrals where necessary
• Manage more patients in the community, thereby reducing the burden of unnecessary hospital admissions and expenditure

For further information, please contact:

Ben Moore, Commercial Development Manager, GSK
Email: benjamin.2.moore@gsk.com

Alison Freemantle, Senior Healthcare Development Manager, Lloydspharmacy
Email: alison.freemantle@lloydspharmacy.co.uk

UK/MA/0044b/11 - September 2011

Durham Dales Health and GlaxoSmithKline are engaged in Joint Working to enhance the management of Chronic Obstructive Pulmonary Disease (COPD) to a standard of care defined by NICE (National Institute for Health and Clinical Excellence).

Both parties have committed resources to support this project, which will run from April 2011 to September 2012

The objective of this Joint Working project is to improve quality and productivity in the management of patients with COPD within the consortium.

It is designed to support:

• Improved quality of life for COPD patients
• The promotion of disease prevention and the earlier identification of patients with COPD through healthcare professional education.
• Accurate diagnosis and classification of disease with access to high quality information.
• Prevention of COPD exacerbations through increased patient review and appropriate use of medications in line with NICE guidance.
• Improving the quality of COPD referrals to secondary care and community teams.
• A reduced need for unscheduled care
• Equitable, cost effective service delivery across all practices in the consortium.

For further information please contact:

Alison Newbolt, Area Business Manager, GSK. Email: alison.j.newbolt@gsk.com

Kathryn Kemp, Integrated Healthcare Manager, GSK

Email: Kathryn.x.kemp@gsk.com

UK/PPM/0112/11 – April 2011

Joint Working Agreement

NHS Dudley Respiratory Local Implementation Team and GlaxoSmithKline UK (GSK) working jointly to improve adult asthma healthcare in the Dudley area.

Both parties have committed resources to support this project, which will run from May 2011 – April 2012

The purpose of this Joint Working project is to improve the quality and productivity in the management of patients with asthma within practices in the Dudley area.

The approach will cover:

• Development of a patient pathway and management protocol.
• Delivery of a bespoke education and training programme for healthcare professionals.
• Deployment of a patient experience questionnaire to assess the impact of the education and training programme on patient care.

The benefits of the project are:

The Patient	NHS Dudley	GlaxoSmithKline
Consistent standard of care and improved concordance in line with current local and national guidelines.	A service that supports the development of healthcare professionals involving training to effectively identify, diagnose and manage adult asthma patients.	This project is intended to create more opportunities for the appropriate use of medicines, including GSK's medicines in suitable patients in line with local guidelines.
Better understanding around the need to manage their condition with access to self management plans and patient literature.	To advise on and promote the appropriate use of medicines to patients in accordance with the local guidelines and the Dudley Health Economy drugs Formulary.	Increased acknowledgment of the role GSK has in supporting NHS Dudley priorities in improving patient management.
Localised care closer to home within primary care and for the housebound.	The development of a patient pathway that integrates services across the health economy.	To case study how joint working between GSK and NHS Dudley has improved the management of asthma in line with the QIPP parameters.

For further information please contact Eddie Melia, Area Business Manager GSK.

Email: edward.x.melia@gsk.com

or Muneer Ladak, Integrated Healthcare Manager GSK.

Email: muneer.x.ladak@gsk.com

UK/PPM/0123/11 – May 2011

Joint Working Agreement

NHS East Midlands and GlaxoSmithKline are engaged in joint working to enhance the management of Chronic Obstructive Pulmonary Disease (COPD) to a standard of care defined by NICE (National Institute for Health and Clinical Excellence).

Both parties have committed resources to support this project, which will run from May 2011 – Feb 2012.

The objective of this Joint Working project is twofold:

• To accelerate NHS East Midlands capability to implement the East Midlands COPD Strategy.
• To improve quality and productivity in the management of patients with COPD within a PBC group.

It is designed to support:

• Mapping of the burden of disease and current service provision in NHS East Midlands.
• Development of a bespoke project plan for the implementation of the East Midlands COPD strategy.
• The promotion of disease prevention and the earlier identification of patients with COPD through healthcare professional education.
• Accurate diagnosis and classification of disease with access to high quality information.
• Prevention of COPD exacerbations through increased patient review and appropriate use of medications in line with NICE guidance.
• Improving the quality of COPD referrals to secondary care and community teams.
• Equitable, cost effective service delivery across all practices in the PBC group.

For further information please contact Charlotte Clarke, Area Business Manager.

GSK. Email: charlotte.x.clarke@gsk.com

UK/PPM/104/11 – May 2011.

South West Kent PBC Group and GlaxoSmithKline are engaged in joint working to enhance the management of Chronic Obstructive Pulmonary Disease (COPD) to a standard of care defined by NICE (National Institute for Health and Clinical Excellence).

Both parties have committed resources to support this project, which will run from August 2010 – August 2011

The objective of this Joint Working project is to improve quality and productivity in the management of patients with COPD within the PBC group.

It is designed to support:

• The promotion of disease prevention and the earlier identification of patients with COPD through healthcare professional education.
• Accurate diagnosis and classification of disease with access to high quality information.
• Prevention of COPD exacerbations through increased patient review and appropriate use of medications in line with NICE guidance.
• Improving the quality of COPD referrals to secondary care and community teams.
• Equitable, cost effective service delivery across all practices in the PBC group.

For further information please contact:

Pauline Mooney, Area Business Manager, GSK.
Email: pauline.e.mooney@gsk.com

UK/PPM/0060/10 - August 2010

Purpose

To improve quality and productivity in the management of patients with COPD in NHS Gloucestershire

Objectives

• Increase efficiency by optimising the patient pathway and reducing inappropriate referrals.
• Deliver improved patient outcomes by raising standards from a QOF standard of care, to a NICE standard of care in the management of COPD. Moving practices away from a 15 month review, due to QOF, and towards a NICE standard of 6-12 month review.
• Improve equality of care by reducing the variability in the management of COPD across practices within NHSG.
• Improved management of COPD exacerbations through increased recording and improved patient review and appropriate use of medications in line with current NICE COPD 2010 guideline.
• To assess the quality of the COPD service (as assessed by patients and HCPs).

Both parties have committed resources to support this project which will run from January 2011 - December 2011.

Background

NHS Gloucestershire has a history of high spend on respiratory medicines but records only an average performance with regards hospital admissions when benchmarked against other PCT's in the South West SHA. A Respiratory Steering Group was formed in 2008 to provide a review of respiratory care in Gloucestershire.

The stated aims of the Gloucestershire Respiratory Steering Group, agreed at the Gloucestershire primary care trust PEC meeting on the 10th February 2009, are:

• To improve the timeliness and comprehensiveness of the service to patients provided by the Healthcare Professional
• To improve the health of patients with respiratory disease or to maintain health at an appropriate level where this is not possible
• To understand why Gloucestershire is an outlier in some aspects of respiratory care utilisation
• To reduce unnecessary hospital admissions through the provision of more comprehensive and responsive services in other settings
• To reduce inappropriate spend on respiratory medicines
• To ensure Gloucestershire is compliant with key national policy on respiratory care

In January 2009 GSK started working in partnership with NHS Gloucestershire on the development and implementation of the COPD care pathway and associated developments.

Based on successful partnership working to date between both parties, it has been agreed that GSK UK and NHS Gloucestershire will continue to work together through the Respiratory Steering Group, and will combine financial and people resource in this Joint Working Project.

For further information contact:

Joanne Murphy, Integrated Healthcare Manager, GlaxoSmithKline.
Email: joanne.s.murphy@gsk.com

Karen Traves, Area Business Manager, GlaxoSmithKline.
Email: karen.x.traves@gsk.com.

UK/PPM/0071/10 – Jan 11